- Home
- INBX vs SDHY Comparison
INBX vs SDHY Comparison
Compare INBX & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INBX | SDHY |
|---|---|---|
| Founded | 2010 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 430.2M | 403.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | INBX | SDHY |
|---|---|---|
| Price | $79.02 | $16.53 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 242.1K | 94.0K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.46% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | ★ $1,400,000.00 | N/A |
| Revenue This Year | $563.00 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.81 | $13.93 |
| 52 Week High | $94.57 | $15.50 |
Technical Indicators
Market Signals| Indicator | INBX | SDHY |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 55.71 |
| Support Level | $76.22 | $16.45 |
| Resistance Level | $94.57 | $16.59 |
| Average True Range (ATR) | 6.98 | 0.12 |
| MACD | -1.37 | 0.02 |
| Stochastic Oscillator | 21.45 | 86.75 |
Price Performance
Historical ComparisonAbout INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It mainly invests in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments (including derivatives) with similar economic characteristics.